Cancer Immunotherapy Market Size to Reach USD 339.6 Billion by 2032 | CAGR: 14.5% | DataHorizzon Research
14 sept. 2023 08h20 HE
|
DataHorizzon Research
Fort Collins, Colorado, Sept. 14, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Cancer Immunotherapy Market Size, Growth, Share, Statistics Report, By Type (Monoclonal...
Cancer Immunotherapy Market Set to Soar Past USD 309.67 Billion by 2030 | Skyquest Technology
17 août 2023 00h48 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest's latest global research of the Cancer Immunotherapy market, increasing adoption of immune checkpoint inhibitors, development...
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
07 août 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on investigational cancer immunotherapy PV-10 (rose bengal...
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
01 août 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from ongoing clinical trials of investigational cancer immunotherapy PV-10 (rose bengal sodium) for...
Advances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New Report
21 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer including...
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
28 juin 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 28, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with the University of Tennessee College of...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.
26 juin 2023 08h01 HE
|
Ocean Biomedical, Inc.
Patent broadens protection around Ocean Biomedical’s first-in-class anti-CHi3L1 antibody to include new bispecific approaches targeting immune checkpoints, with potential application in multiple...
Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
26 juin 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 26, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’s Board of Directors (Board) to seek...
Global Breast Cancer Immunotherapy Market Size & Trends
20 juin 2023 10h08 HE
|
Global Market Estimates
Brooklyn, New York, June 20, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Breast Cancer Immunotherapy Market is projected to...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
13 juin 2023 04h48 HE
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...